Efficacy and safety of once-daily tacrolimus extended-release formulation in allogeneic haematopoietic stem cell transplantation patients

被引：0
作者：
Katayama, Y.
Iwato, K.
Ochi, T.
Okatani, T.
Imanaka, R.
Kyo, K.
Itagaki, M.
Asaoku, H.
Kyo, T.
机构：
[1] Hiroshima Red Cross Hosp, Hiroshima, Japan
[2] Atom Bomb Survivors Hosp, Hiroshima, Japan
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S445 / S445
页数：1
相关论文
共 50 条
  • [21] Once-Daily Tacrolimus Extended Release Formulation: A Hemodynamic Study in Stable Liver Transplant Patients
    Orozco, Federico
    Anders, Margarita
    Alvarez, Daniel
    Quinonez, Emilio
    Goldaracena, Nicolas
    Chao, Sara
    McCormack, Lucas
    Mastai, Ricardo
    LIVER TRANSPLANTATION, 2012, 18 : S153 - S153
  • [22] Efficacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease
    Schapira, A.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Poewe, W.
    Rascol, O.
    Busse, M.
    Juhel, N.
    Salin, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S133 - S133
  • [23] Long-term efficacy and safety of once-daily oral extended-release hydromorphone.
    Swanton, R
    Buckley, B
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09) : 1068 - 1068
  • [24] Two-year safety and efficacy of once-daily extended-release macin/lovastatin in patients with hypercholesterolemia.
    Kashyap, ML
    Stanek, EJ
    Simmons, PD
    McGovern, ME
    PHARMACOTHERAPY, 2005, 25 (10): : 1434 - 1434
  • [25] Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease
    Perez Lloret, Santiago
    Rascol, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2221 - 2230
  • [26] Efficacy and safety of once-daily dexmethylphenidate extended-release capsules in pediatric patients with attention-deficit disorder
    Greenhill, LL
    Litt, F
    Jiang, H
    Guerra, Y
    Muniz, R
    ANNALS OF NEUROLOGY, 2004, 56 : S107 - S107
  • [27] Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women
    Fourcroy, JL
    Berner, B
    Chiang, YK
    Cramer, M
    Rowe, L
    Shore, N
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 4137 - 4143
  • [28] Evaluation of Flexible Tacrolimus Drug Concentration Monitoring Approach in Patients Receiving Extended-Release Once-Daily Tacrolimus Tablets
    Philosophe, Benjamin
    Leca, Nicolae
    West-Thielke, Patricia M.
    Horwedel, Timothy
    Culkin-Gemmell, Christine
    Kistler, Kristin
    Stevens, Daniel R.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (07) : 891 - 896
  • [29] Pharmacokinetic properties of a once-daily formulation of tacrolimus in patients with renal transplantation
    Imanishi, Yoshinori
    Matsui, Kumi
    Ishida, Kenichiro
    Ito, Shin-ichi
    Matsuura, Katsuhiko
    Deguchi, Takashi
    Itoh, Yoshinori
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2011, 61 (03): : 191 - 196
  • [30] ECONOMIC IMPACT OF ONCE-DAILY MELTDOSE EXTENDED-RELEASE TACROLIMUS (LCP-TAC) IN PATIENTS WITH KIDNEY OR LIVER TRANSPLANTATION IN SPAIN
    Solozabal, M.
    Tarragona, E.
    Gonzalez-Dominguez, A.
    Querol, D.
    Galindo, J., V
    VALUE IN HEALTH, 2022, 25 (01) : S84 - S84
12345